Diabetes Board decisions

The Board denied the veteran's appeals for increased ratings and service connection, as the claims were not timely filed or the evidence did not support a nexus to service.

The Board remands the claims for further development, including a new VA examination to determine the nature and etiology of the Veteran's diabetes mellitus and diabetic peripheral neuropathies.

The Board remands the claims for service connection for diabetes mellitus, type II, Parkinson's disease, and hypertension to obtain a medical opinion pursuant to the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022 (PACT Act).

The Board granted service connection for erectile dysfunction and earlier effective dates for the awards of service connection for left hip degenerative arthritis, right hip degenerative arthritis, and tinnitus. It also granted a TDIU from September 24, 2021, and basic eligibility for Dependents' Educational Assistance (DEA) from that date.

The Board denied service connection for diabetes mellitus, hypertension, and diabetic peripheral neuropathy in the upper extremities as they were not shown to be causally or etiologically related to any disease, injury, or incident during service, including exposure to contaminated water at Camp Lejeune.

The Board denied service connection for diabetes mellitus Type II, left lower extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and thyroid cancer as there was no evidence of in-service incurrence or a causal relationship between the claimed conditions and the Veteran's military service.

The appeal for service connection for sleep apnea was granted, while other claims were denied or remanded. The low back disability claim was dismissed.

The Board granted service connection for prostate cancer, dementia, tremors, hypertension, diabetes mellitus, type 2, and a low back condition.

The Board granted service connection for type II diabetes mellitus based on the Veteran's exposure to herbicides during his service at Royal Thai Air Base U-Tapao, in line with the PACT Act.

The Board dismissed the appeal for service connection for degenerative joint disease of the right knee, right shoulder, left shoulder, and left knee as well as diabetes mellitus type II due to an untimely Notice of Disagreement (NOD) filed more than one year after the initial denial.

The Board granted service connection for hypertension due to herbicide exposure and denied service connection for diabetes mellitus. Rheumatoid arthritis, a left hip condition, tongue cancer, and neck cancer were remanded for further development.

The Board granted presumptive service connection for tinnitus, but remanded the claims for other conditions due to a duty to assist error.

The Board granted service connection for the cause of the Veteran's death, finding that his lung cancer was at least as likely as not directly related to in-service exposure to contaminated water at Camp Lejeune.

The Board denied an earlier effective date for the grant of service connection for diabetic nephropathy, finding that the criteria were not met.

The Board remands the Veteran's claims for service connection for a low back disability, bilateral pes planus, neck disability, diabetes mellitus, type II, hypertension (claimed as high blood pressure), and erectile dysfunction to correct an error by the AOJ to satisfy its duty to assist the claimant under 38 U.S.C. § 5103A.

The Board granted service connection for type II diabetes mellitus and peripheral neuropathy, left lower extremity, resolving reasonable doubt in the Veteran's favor.

The Board remands the claim for service connection of diabetes mellitus, type II to obtain an addendum opinion addressing the etiology of the condition in relation to alleged in-service exposure to chemical toxins.

The Board remands the claims for service connection and increased ratings, as well as the claim for an earlier effective date for DEA benefits, to ensure that all relevant evidence is obtained.

The Board denied the claims for earlier effective dates, increased ratings, and service connection due to insufficient evidence linking the conditions to active service or other presumptive exposures.

The Board granted service connection for diabetes mellitus, type II and non-Hodgkin's lymphoma under the PACT Act but denied service connection for multiple myeloma. The claims for service connection on a basis other than the PACT Act were remanded.